Senior Technical Lead
Hind Satti is the Lead HIV/Tuberculosis (TB) Advisor in the HIV division of the Infectious Diseases and Health Systems department at FHI 360. She provides technical assistance and strategic direction to the Meeting Targets and Maintaining Epidemic Control (EpiC) project and other USAID/PEPFAR-funded programs.
Prior to joining FHI 360, Satti was Executive Director for Partners In Health (PIH)-Lesotho for over 10 years, where she was responsible for its strategic direction, design and implementation of integrated HIV and TB/drug resistant-TB and maternal and child health programs, strengthening national program performance, and working on innovation, transformation and large-scale spread in close partnership with the Lesotho Ministry of Health (MOH). In 2013, the Government of Lesotho recognized this work by asking PIH-Lesotho to lead health sector reform efforts. Under Satti’s leadership, PIH’s multidrug-resistant-TB/HIV program became the national treatment program in the country and a model for Africa. She managed a team of 206 health professionals and over 2,000 community health workers and oversaw health projects supported by multiple funders including The Global Fund, USAID, PEPFAR, World Bank and other multilateral and bilateral funders.
Satti assumed the role of Deputy Chief Medical Director at Partners in Health. In this role, she led the clinical and management teams in 12 countries by coordinating, designing and supporting implementation of HIV and TB projects. She pioneered the application of the universal health coverage (UHC) tool for collaborative methodology and integration improvements for HIV, TB and maternal and child health in several low- and middle-income countries. She helped developed the World Health Organization (WHO) strategy for designing and scaling drug resistant-TB treatment and care to meet global targets.
Satti is graduate of the Department of Global Health and Social Medicine at Harvard Medical School. She is also an associate in the Division of Global Health Equity at Brigham and Women’s Hospital. She is a member of the Global Drug-Resistant TB Initiative (GDI) and member of the Drug-Resistant TB for the Regional Green Light Committee for WHO/AFRO which she previously chaired. She is also a member of the Technical Review Panel at the Global Fund to Fight AIDS, Tuberculosis and Malaria.